结直肠癌人群数据中衰弱测量工具的比较
该回顾性人群研究基于英格兰国家医疗服务体系136,008例结直肠癌患者,评估医院衰弱风险评分(HFRS)、二级护理行政记录衰弱指数(SCARF)和衰弱综合征(FS)的可行性、效度和信度。三种工具均可行、有效且可靠,但衰弱患病率不同;HFRS和FS在最低与最高衰弱水平之间的1年总生存差异最大,模型性能差异微小。
要点
- HFRS、SCARF和FS均可在常规行政医疗数据中量化衰弱。
- SCARF将55.4%人群归入最低风险组,HFRS为85.1%,FS为81.2%。
- HFRS和FS在最低与最高衰弱水平间的1年总生存差异最大。
核心结论
- HFRS、SCARF和FS均有价值用于在常规行政医疗数据集中量化衰弱。
- 最合适的测量工具取决于每项流行病学研究的具体背景和要求。
研究设计与样本
- 回顾性人群研究,使用英格兰国家医疗服务体系内136,008例结直肠癌患者。
主要发现
- 所有测量工具均展示可行性、效度和信度。
- SCARF和CCI使用的诊断编码有相当程度的重叠。
- 各工具确定的衰弱患病率不同:SCARF将55.4%人群归入最低风险组,HFRS为85.1%,FS为81.2%。
- HFRS和FS在最低与最高衰弱水平之间的1年总生存差异最大。
- 包含各工具的模型性能差异微小。
关键数值与推荐
- SCARF将55.4%人群归入最低风险组,HFRS为85.1%,FS为81.2%。
- 使用Brier评分和c统计量评估模型性能和区分能力。
临床怎么用
- 在结直肠癌人群研究中量化衰弱时,可根据研究背景和需求选择HFRS、SCARF或FS。
- 需注意不同工具得出的衰弱患病率存在差异,可能影响风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Numerous studies have revealed age-related inequalities in colorectal cancer care. Increasing levels of frailty in an ageing population may be contributing to this, but quantifying frailty in population-based studies is challenging. OBJECTIVE: To assess the feasibility, validity and reliability of the Hospital Frailty Risk Score (HFRS), the Secondary Care Administrative Records Frailty (SCARF) index and the frailty syndromes (FS) measures in a national colorectal cancer cohort. DESIGN: Retrospective population-based study using 136,008 patients with colorectal cancer treated within the English National Health Service. METHODS: Each measure was generated in the dataset to assess their feasibility. The diagnostic codes used in each measure were compared with those in the Charlson Comorbidity Index (CCI). Validity was assessed using the prevalence of frailty and relationship with 1-year survival. The Brier score and the c-statistic were used to assess performance and discriminative ability of models with included each measure. RESULTS: All measures demonstrated feasibility, validity and reliability. Diagnostic codes used in SCARF and CCI have considerable overlap. Prevalence of frailty determined by each differed; SCARF allocating 55.4% of the population to the lowest risk group compared with 85.1% (HFRS) and 81.2% (FS). HFRS and FS demonstrated the greatest difference in 1-year overall survival between those with the lowest and highest measured levels of frailty. Differences in model performance were marginal. CONCLUSIONS: HFRS, SCARF and FS all have value in quantifying frailty in routine administrative health care datasets. The most suitable measure will depend on the context and requirements of each individual epidemiological study.
引用
- Birch R, Taylor J, Rahman T, et al. A comparison of frailty measures in population-based data for patients with colorectal cancer. Age Ageing. 2024. PMID: 38783754. doi:10.1093/ageing/afae105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。